Technology Solutions Demo Request
Streamline participant payments with automated workflows that simplify stipends, reimbursements, and tracking for coordinators, participants, and finance teams.
Conversion
Advarra Study Collaboration Solution
The future of study startup gives sites flexibility, while ensuring total visibility for study teams like yours. Optimize operations across each unique site, with guided configurations to ensure compliance and control.
Advarra Enroll Contact Request
Streamline participant payments with automated workflows that simplify stipends, reimbursements, and tracking for coordinators, participants, and finance teams.
The Ohio State eReg Case Study
This white paper examines four KPIs most impacting timelines and budgets and offers strategies for effective communication and risk mitigation.
IRB Technology Demo Request
Streamline participant payments with automated workflows that simplify stipends, reimbursements, and tracking for coordinators, participants, and finance teams.
Advarra Enroll Info Sheet
Set up sites for recruitment success with the only site-sponsor collaboration solution integrated into the site’s study startup workflow.
Advarra Study Startup Info Sheet
Guide sites and study teams with the only site-sponsor collaboration solution that provides immediate visibility, helping you hit every milestone on time.
Participant Payments for OnCore
Simplify and streamline clinical trial participant reimbursements and stipends with Advarra Payments.
CCPay
CCPay enables clinical trial sites to streamline participant payment workflows, track payments in real time, and enhance overall financial management.
Advarra Study Startup Contact Us
The easiest way to guide sites through the activation process Advarra Study Startup is the only study collaboration software that
Clinical Research Staffing
Reduce the burden of testing and documentation with precompiled validation materials, available through an annual subscription.
Central Oncology Review
Advarra meets the growing needs of oncology by offering robust human subject protections that cancer research institutions expect.